197 related articles for article (PubMed ID: 34006247)
1. Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review.
Chan CWH; Law BMH; Ng MSN; Wong CCY; Wong CWY; Quinley M; Orgusyan JM; Chow KM; Waye MMY
BMC Cancer; 2021 May; 21(1):570. PubMed ID: 34006247
[TBL] [Abstract][Full Text] [Related]
2. British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer.
Marsden J; Marsh M; Rigg A;
Post Reprod Health; 2019 Mar; 25(1):21-32. PubMed ID: 30776968
[TBL] [Abstract][Full Text] [Related]
3. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
Lintermans A; Van Asten K; Jongen L; Van Brussel T; Laenen A; Verhaeghe J; Vanderschueren D; Lambrechts D; Neven P
Eur J Cancer; 2016 Mar; 56():31-36. PubMed ID: 26798969
[TBL] [Abstract][Full Text] [Related]
4. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer.
Baumgart J; Nilsson K; Stavreus-Evers A; Kask K; Villman K; Lindman H; Kallak T; Sundström-Poromaa I
Am J Obstet Gynecol; 2011 Jan; 204(1):26.e1-7. PubMed ID: 20950790
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.
Goetz MP; Rae JM; Suman VJ; Safgren SL; Ames MM; Visscher DW; Reynolds C; Couch FJ; Lingle WL; Flockhart DA; Desta Z; Perez EA; Ingle JN
J Clin Oncol; 2005 Dec; 23(36):9312-8. PubMed ID: 16361630
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
Dezentjé VO; Gelderblom H; Van Schaik RH; Vletter-Bogaartz JM; Van der Straaten T; Wessels JA; Kranenbarg EM; Berns EM; Seynaeve C; Putter H; Van de Velde CJ; Nortier JW; Guchelaar HJ
Breast Cancer Res Treat; 2014 Jan; 143(1):171-9. PubMed ID: 24265036
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in Malaysia.
Choo SB; Saifulbahri A; Zullkifli SN; Fadzil ML; Redzuan AM; Abdullah N; Bustamam RSA; Ahmad HZ; Shah NM
Climacteric; 2019 Apr; 22(2):175-181. PubMed ID: 30556740
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
Singh MS; Francis PA; Michael M
Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22.
Baxter SD; Teft WA; Choi YH; Winquist E; Kim RB
Breast Cancer Res Treat; 2014 Jun; 145(2):419-28. PubMed ID: 24744093
[TBL] [Abstract][Full Text] [Related]
10. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.
Cuzick J; Sestak I; Cella D; Fallowfield L;
Lancet Oncol; 2008 Dec; 9(12):1143-8. PubMed ID: 18976959
[TBL] [Abstract][Full Text] [Related]
11. Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Johansson H; Gray KP; Pagani O; Regan MM; Viale G; Aristarco V; Macis D; Puccio A; Roux S; Maibach R; Colleoni M; Rabaglio M; Price KN; Coates AS; Gelber RD; Goldhirsch A; Kammler R; Bonanni B; Walley BA;
Breast Cancer Res; 2016 Nov; 18(1):110. PubMed ID: 27825388
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
Morales L; Neven P; Timmerman D; Christiaens MR; Vergote I; Van Limbergen E; Carbonez A; Van Huffel S; Ameye L; Paridaens R
Anticancer Drugs; 2004 Sep; 15(8):753-60. PubMed ID: 15494636
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant).
Chan CWH; Miaskowski C; McCarthy A; Waye MMY; Yeo W; So WKW; Choi KC; Tsui SKW; Chan JYW
Medicine (Baltimore); 2020 Feb; 99(8):e19083. PubMed ID: 32080081
[TBL] [Abstract][Full Text] [Related]
14. Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis.
Chan CWH; Li C; Xiao EJ; Li M; Phiri PGM; Yan T; Chan JYW
Expert Rev Mol Med; 2022 Jan; 24():e1. PubMed ID: 34991754
[TBL] [Abstract][Full Text] [Related]
15. Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study.
Puszkiel A; Arellano C; Vachoux C; Evrard A; Le Morvan V; Boyer JC; Robert J; Delmas C; Dalenc F; Debled M; Venat-Bouvet L; Jacot W; Suc E; Sillet-Bach I; Filleron T; Roché H; Chatelut E; White-Koning M; Thomas F
Clin Pharmacol Ther; 2019 Sep; 106(3):585-595. PubMed ID: 30786012
[TBL] [Abstract][Full Text] [Related]
16. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
[TBL] [Abstract][Full Text] [Related]
17. [Vaginal oestrogen therapy in women with hormone-sensitive breast cancer].
Bak AM; Laursen BE; Rungby J; Brock B
Ugeskr Laeger; 2011 Feb; 173(9):648-51. PubMed ID: 21362392
[TBL] [Abstract][Full Text] [Related]
18. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
[TBL] [Abstract][Full Text] [Related]
19. Symptoms associated with oophorectomy and tamoxifen treatment for breast cancer in premenopausal Vietnamese women.
Love RR; Nguyen BD; Nguyen CB; Nguyen VD; Havighurst TC
Breast Cancer Res Treat; 1999 Dec; 58(3):281-6. PubMed ID: 10718489
[TBL] [Abstract][Full Text] [Related]
20. Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.
Jeong YJ; Park YS; Kwon HJ; Shin IH; Bong JG; Park SH
J Altern Complement Med; 2013 Aug; 19(8):690-6. PubMed ID: 23383974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
